I'm a self-employed technical translator, German --> English. I have the NI pension and a SIPP pension fund, plus some dividend-bearing stocks, which will enable the transition from earned income to unearned income. I'm also interested in potential large capital gains, but without jeopardizing my baseload income.
I'm a computer engineer with a great interest in finance. I'm not a pro, I do it for my family. But I'll share what I know and try to be as helpful as I can. I own about 10% of my assets in precious metals. As for currencies, I keep about 75% CAD vs 25% USD of my assets. I have about 35% in mutual funds; global small cap, global fixed income and global real estate. These allocations are fully managed by me, but I re-balance twice a year or so. That mutual fund core is insuring sufficient diversification and low correlation to the following US and Canada single stocks.
About another 35% is a trusted core of single stocks, both Canada and US. These positions are generally overweight at about 3% of portfolio. Core positions have a few properties in my portfolio: low turn-over, very long term, low debt, often dividend growers with low payouts, good valuations, good growth, low beta. They are safe and feel safe, and I usually build those position over the years. I consider it core after 2 years of reliable service. A stock can gain my trust by presenting profits. Not much mega caps, mostly small to medium caps. Another property of my core: easy to understand businesses. They wash linen, they sell groceries, they make boxes, they produce wine. As I build confidence and understanding, I allow more exotic positions in core. They manage money, they rent retirement houses, they dig for metals, they patent software, etc.
At the other extreme, I keep a few lottery tickets as satellite positions for about 20% of portfolio total, 0.75% to 1.5% of portfolio each position. More risky or difficult to understand business, more volatile and some signs of stink. Could be reversal plays, could be momentum stocks, can display signs of breaking out. Usually, I rely a little more on technicals than fundamentals there. And I trade. I learn. I make mistakes. I churn. Survival of the fittest.
I always look for dips in my core positions, and I wait for clear signals to buy back (volume, a few moving avg). If I have cash, I use it. If I don't I look at core and I trim large gains. If no gains there, I look at satellites for gains. If no gains, I look at satellites for mistakes, stinkers, unreliable bets. With money, I buy dips in core positions or in-the-middle stocks. In middle stocks are first buys aiming core, or rising satellites gaining confidence and improving.
Here's my complete stock, ETF, mutual funds and precious metal portfolio as of mid-March 2016, with position size:
MUTUAL Global Equity Small Cap - Mawer (20%)
MUTUAL Global Fixed Income - PIMCO (17%)
PM Physical Silver and Gold coins (11%)
MUTUAL Global Real Estate - Pyramis (4.5%)
ADW.TO Andrew Peller Inc (3%)
SXP.TO Supremex (3%)
KBL.TO K-Bro Linen Inc (3%)
DIS Walt Disney Co (3%)
ATD.TO Alimentation Couche-Tard Inc (3%)
SIS.TO Savaria Corporation (3%)
RCH.TO Richelieu Hardware Ltd (3%)
MST.TO Milestone Apartments Real Estate Investment Trust (3%)
RC.TO RDM Corp (2.5%)
RPI.TO Richards Packaging (2.5%)
LAS.A.TO Lassonde Industries Inc (2.5%)
ITP.TO Intertape Polymer Group Inc (2.5%)
WPK.TO Winpak Ltd (2.5%)
SAP.TO Saputo Inc (2%)
MRU.TO Metro Inc (2%)
TCN.TO Tricon Capital Group Inc (2%)
PJP PowerShares Dynamic Pharmaceuticals Portfolio (2%)
UHAL Amerco (2%)
TIP iShares TIP Bonds (2%)
SRCL Stericycle (2%)
BAM.TO Brookfield Asset Management Inc (2%)
PSI.TO Pason Systems (2%)
TMA.TO Trimac Transportation (1.5%)
CCL.TO CCL Industries Inc (1.5%)
PHO.TO Photon Control Inc (1.5%)
SYZ.TO Sylogist Ltd (1.5%)
ADN.TO Acadian Timber Corp (1.5%)
ACLS Axcelis Technologies (1.5%)
ENF.TO Enbridge Income Fund (1%)
LGT.B.TO Logistec Corporation (1%)
AWK American WaterWorks (1%)
SYT Syngenta (1%)
UVE Universal Insurance Holdings, Inc (0.75%)
XPLT.TO XPEL Technologies (0.5%)
VCM.TO Vecima Networks (0.5%)
QST.TO Questor Technology (0.5%)
IWG.TO IWG Technologies (0.5%)
CASH -- CASH -- CASH -- CASH (0.25%)
I started following the stock market few years ago.
After a couple of wrong bets and bad advises, I have decided to take charge of my money! Do some studies on the matter and try to understand better the stock market mouvements, in order to maxime my utility in each investments.
I'm an amateur, and doing this on my spare times only.
Sorry for the Run-on sentences in advance. If you have any questions about my research or any data related to my blogs, just inquire about them via comment.
I am a 20 year old finance student studying the pharmaceutical industry and in particular the top performing industries of Biotech and life science research. I research companies that target untapped markets and follow capital expenditure trends of the industry to capitalize on surrounding opportunities. Companies working with government funded research institutions (NIH, Foundations, Universities) are my favorite long picks. I am long small caps with strong pipelines and balance sheets, and short most one trick unicorns that don't have value or technical support. I pick my trades on a company by company basis. I don't always require that a company is involved in a favorable industry that has unmet demand by big pharma, but that is where I believe discrepancies in valuations occur most often. Recently, I have moved with momentum and enjoy testing hype in valuations.
I use fundamental analysis, some historical pricing model techniques, and ultimately, macro themes to build and test my thesis's for industry analysis and trading. I always trade on technical analysis, but find value in fundamentals.
In 2016, my Biotech industry top picks are involved in the clinical development of therapies in ophthalmology (Dry eye, DME, AMD), rare diseases (MF, Lupus, DMD), lung disorders (COPD), cardiovascular diseases (PAH, DCM, CLI), and breakthrough cancer therapies (so basically anything Celgene, Roche, and Novartis miss).
Expecting a lot of crowding in Melanoma (ex. RXDX, ARRY) and cholesterol drugs (ex. $ESPR, $AEGR) in 2016 with multiple expected drug launches. Finally, I am excited for Biosimilars to make their debut in 2016. Many patent expirations in 2017 and before 2019 should open up some serious patent cases. I am still expecting a ton of BLAs to be filed in 2016 (ex. $PFNX, $EPRS, $MNTA, $SRNE).
Thanks for reading, tweet @Kuritzmike if you want to see what I'm trading on the day to day.
Part-time trader with a small budget to play with. I'm trying to learn how to keep my head above water in the trading world and after I stop inhaling water on every trade, I'll increase that budget and actually attempt to make some money.
Old enough to been around the block a couple of times but young enough to still enjoy the ride. Ex-engineer who believes if he was smart enough to design medical devices he should be smart enough to make money off trading. Remains to be seen.
private investor....former student in bio tech ....interested in advancing practical and economical sources of treatment for human welfare with dignity an awareness . methodical research can be done with new technology with a much more efficient an timely manner...especially vaccines developed thru research more than a decade ago....Why an Who is creating the lengthy timeline to get these cancer vaccines to patients....We can send discover satellites to another solar system an RETRIEVE the DATA ! WE as a generation are mapping our entire solar system an beyond...OUR government has a duty to protect its citizens not only by man/made laws, but the very law of NATURE demands accountability from its leaders....I am saddened by their methods.!
BA Philosophy with a focus on epistemology. I have only been investing since March of 2013. I'm self taught. Anything I may write here on Seeking Alpha is purely to inform others and is not meant as investing advice.
Part time trader, Basically long term investor, but here and there make some short term trades, (I'm still young, could digest some risk).
Former New Yorker, Love the state of Georgia!